Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.
2022
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
Tipo pubblicazione
Letter
Autori/Collaboratori (28)Vedi tutti...
Passerini SG
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
Macagno N
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
Cariti C
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
et alii...
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
Macagno N
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
Cariti C
Department of Medical Sciences, Section?of Dermatology, University of Turin, Torino, Italy.
et alii...
Accesso banca dati bibliografica
Accedi alla scheda bibliografica del documento in PUBMED
Se sei accreditato in BVS-P effettua prima l'accesso per utilizzare i nostri servizi.
PMID : 35686942
DOI : 10.1111/jdv.18314
Keywords
Psoriasis/drug therapy; Humans; Antibodies, Monoclonal;